Swiss Biotech Day 2025
May 5-6, Basel, Switzerland
Our Attendees:
Dr. Atef Halabi
Board Certified Internist
Renal & Hepatic Advisor
Senior Strategic Advisor
atef.halabi@crs-group.de
Francesca Mannella
Business Development Manager
francesca.mannella@crs-group.de
Who is CRS?
At Swiss Biotech Day 2025, CRS Clinical Research Services is excited to engage with industry leaders and discuss the future of clinical trials. We’ll be exploring how the evolving landscape of clinical research, regulatory changes, and new technologies are shaping the way studies are conducted. Our team looks forward to engaging in meaningful discussions around improving patient access, accelerating timelines, and enhancing trial efficiencies to help bring new therapies to market faster.
With over 45 years of experience in running Phase I-II trials across multiple therapeutic areas, CRS offers comprehensive clinical research services that support the rapid development of new medicines. Our expertise includes managing early-phase clinical trials from First-in-Human to Proof-of-Concept, ensuring high-quality results that adhere to the highest standards of safety and regulatory compliance.
A key highlight of our work includes our collaboration with leading pharmaceutical companies, providing seamless services from study design through to data analysis. Our ability to conduct complex studies in challenging therapeutic areas has been instrumental in the successful development of novel treatments.
CRS operates world-class clinical trial facilities and maintains a network of specialized labs and hospitals to support a wide range of clinical research needs. Our integrated approach, which includes Pre-/Non-Clinical consultancy services at Venn Life Sciences, ensures that studies are executed with the highest level of scientific rigor, regulatory compliance, and operational efficiency.
We invite you to meet with our team at Swiss Biotech Day to discuss potential collaborations and learn how CRS Clinical Research Services can help you advance the development of cutting-edge therapies.
About CRS
CRS Clinical Research Services is one of Europe’s leading Early Phase Clinical Research Organizations (CROs), specializing in Phase I and II trials. With over 45 years of experience, CRS delivers high-quality, patient-centered clinical research across a broad spectrum of therapeutic areas.
About Venn
Venn Life Sciences is an Integrated Drug Development partner offering a unique combination of drug development consultancy, clinical trial design and execution.
About hVIVO
hVIVO is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials, providing end-to-end early clinical development services for their broad and longstanding global client base of biopharma companies.
Get in Touch
Find us at Booth 89 or on Linkedin!